Gastric epithelial dysplasia: The Western perspective

Digestive and Liver Disease

Volumn 40, Issue 8, 2008, Pages 641-649

  Srivastava, A ^a   Lauwers, G Y ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gastric dysplasia; Gastric non invasive neoplasia; Gastric precancerous lesions; Padova classification

Indexed keywords

APC PROTEIN; K RAS PROTEIN; PROTEIN MLH1; PROTEIN P53;

CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CHROMOENDOSCOPY; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; GASTRECTOMY; GASTRIC EPITHELIAL DYSPLASIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LAMINA PROPRIA; MICROSATELLITE INSTABILITY; PRECANCER; RISK ASSESSMENT; SHORT SURVEY; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADENOMA; DISEASE PROGRESSION; EPITHELIUM; GASTRIC MUCOSA; HUMANS; PRECANCEROUS CONDITIONS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 44949224229     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.039     Document Type: Short Survey

References (108)

1. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3560
2. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 (1991) 1127-1131
3. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., and Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325 (1991) 1132-1136
4. Hill M. Epidemiology and mechanism of gastric carcinogenesis. In: Reed P.I., Carboni M., Johnston B.J., and Guadagni S. (Eds). New trends in gastric cancer background and videoscopy (1989), Kluwer Academic, London 3-12
5. EUROGAST. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993;341:1359-62.
6. Baik S.C., Youn H.S., Chung M.H., Lee W.K., Cho M.J., Ko G.H., et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 56 (1996) 1279-1282
7. Asaka M., Takeda H., Sugiyama T., and Kato M. What role does Helicobacter pylori play in gastric cancer?. Gastroenterology 113 (1997) S56-S60
8. Jass J.R. Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 33 (1980) 801-810
9. Correa P., and Tahara E. Stomach. In: Henson D., and Albores-Saavedra J. (Eds). Pathology of incipient neoplasia (1993), WB Saunders, Philadelphia
10. Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 6 (1980) 98-108
11. Correa P. Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol 12 (1985) 2-10
12. Lewin K., and Appleman H. Atlas of tumor pathology: tumors of the esophagus and stomach (1996), Armed Forces Institute of Pathology, Washington, DC Third series
13. Oehlert W., Keller P., Henke M., and Strauch M. Gastric mucosal dysplasia: what is its clinical significance?. Front Gastrointest Res 4 (1979) 173-182
14. Zhang Y. Typing and grading of gastric dysplasia. In: Zhang Y., and Kawai K. (Eds). Precancerous conditions and lesions of the stomach (1993), Springer-Verlag, Berlin 64-84
15. Serck-Hanssen A. Precancerous lesions of the stomach. Scand J Gastroenterol Suppl 54 (1979) 104-105
16. Farinati F., Rugge M., Di Mario F., Valiante F., and Baffa R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients A prospective study. I.G.G.E.D. - Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy 25 (1993) 261-264
17. Camilleri J.P., Potet F., Amat C., and Molas G. Gastric mucosal dysplasia: preliminary results of a prospective study of patients followed for periods of up to six years. In: Ming S.C. (Ed). Precursors of gastric cancer (1984), Praeger, New York 83-92
18. Bearzi I., Brancorsini D., Santinelli A., Rezai B., Mannello B., and Ranaldi R. Gastric dysplasia: a ten-year follow-up study. Pathol Res Pract 190 (1994) 61-68
19. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo C., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
20. Graem N., Fischer A.B., and Beck H. Dysplasia and carcinoma in the Billroth II resected stomach 27-35 years post-operatively. Acta Pathol Microbiol Immunol Scand [A] 92 (1984) 185-188
21. Aste H., Sciallero S., Pugliese V., and Gennaro M. The clinical significance of gastric epithelial dysplasia. Endoscopy 18 (1986) 174-176
22. Ye W., and Nyren O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut 52 (2003) 938-941
23. Watanabe H., Enjoji M., Yao T., and Ohsato K. Gastric lesions in familial adenomatosis coli: their incidence and histologic analysis. Hum Pathol 9 (1978) 269-283
24. Bulow S., Lauritsen K.B., Johansen A., Svendsen L.B., and Sondergaard J.O. Gastroduodenal polyps in familial polyposis coli. Dis Colon Rectum 28 (1985) 90-93
25. Burt R.W., Berenson M.M., Lee R.G., Tolman K.G., Freston J.W., and Gardner E.J. Upper gastrointestinal polyps in Gardner's syndrome. Gastroenterology 86 (1984) 295-301
26. Shemesh E., and Bat L. A prospective evaluation of the upper gastrointestinal tract and periampullary region in patients with Gardner syndrome. Am J Gastroenterol 80 (1985) 825-827
27. Sarre R.G., Frost A.G., Jagelman D.G., Petras R.E., Sivak M.V., and McGannon E. Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. Gut 28 (1987) 306-314
28. Domizio P., Talbot I.C., Spigelman A.D., Williams C.B., and Phillips R.K. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 43 (1990) 738-743
29. Goedde T.A., Rodriguez-Bigas M.A., Herrera L., and Petrelli N.J. Gastroduodenal polyps in familial adenomatous polyposis. Surg Oncol 1 (1992) 357-361
30. Sawada T., and Muto T. Familial adenomatous polyposis: should patients undergo surveillance of the upper gastrointestinal tract?. Endoscopy 27 (1995) 6-11
31. Bertoni G., Sassatelli R., Nigrisoli E., Pennazio M., Tansini P., Arrigoni A., et al. Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol 31 (1999) 192-197
32. Iida M., Yao T., Itoh H., Watanabe H., Matsui T., Iwashita A., et al. Natural history of gastric adenomas in patients with familial adenomatosis coli/Gardner's syndrome. Cancer 61 (1988) 605-611
33. Utsunomiya J., Maki T., Iwama T., Matsunaga Y., and Ichikawa T. Gastric lesion of familial polyposis coli. Cancer 34 (1974) 745-754
34. Spigelman A.D., Williams C.B., Talbot I.C., Domizio P., and Phillips R.K. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2 (1989) 783-785
35. Kondo K. Duodenogastric reflux and gastric stump carcinoma. Gastric Cancer 5 (2002) 16-22
36. Bassily R., Smallwood R.A., and Crotty B. Risk of gastric cancer is not increased after partial gastrectomy. J Gastroenterol Hepatol 15 (2000) 762-765
37. Wood M.G., Bates C., Brown R.C., and Losowsky M.S. Intramucosal carcinoma of the gastric antrum complicating Menetrier's disease. J Clin Pathol 36 (1983) 1071-1075
38. Shinmura K., Goto M., Tao H., Shimizu S., Otsuki Y., Kobayashi H., et al. A novel STK11 germline mutation in two siblings with Peutz-Jeghers syndrome complicated by primary gastric cancer. Clin Genet 67 (2005) 81-86
39. Goldstein N.S., and Lewin K.J. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol 28 (1997) 127-133
40. Riddell R.H., and Iwafuchi M. Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable?. Histopathology 33 (1998) 197-202
41. Schlemper R.J., Kato Y., and Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol 36 (2001) 445-456
42. Schlemper R.J., Itabashi M., Kato Y., Lewin K.J., Riddell R.H., Shimoda T., et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 349 (1997) 1725-1729
43. Lauwers G.Y., and Riddell R.H. Gastric epithelial dysplasia. Gut 45 (1999) 784-790
44. Morson B.C., Sobin L.H., Grundmann E., Johansen A., Nagayo T., and Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 33 (1980) 711-721
45. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14 (1983) 931-968
46. Ming S.C., Bajtai A., Correa P., Elster K., Jarvi O.H., Munoz N., et al. Gastric dysplasia Significance and pathologic criteria. Cancer 54 (1984) 1794-1801
47. Rugge M., Farinati F., Di Mario F., Baffa R., Valiante F., and Cardin F. Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. Hum Pathol 22 (1991) 1002-1008
48. Rugge M., Correa P., Dixon M.F., Hattori T., Leandro G., Lewin K., et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 24 (2000) 167-176
49. Schlemper R.J., Riddell R.H., Kato Y., Borchard F., Cooper H.S., Dawsey S.M., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 (2000) 251-255
50. In: Hamilton S., and Aaltonen L. (Eds). Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon, France
51. Jass J.R. A classification of gastric dysplasia. Histopathology 7 (1983) 181-193
52. Abraham S.C., Montgomery E.A., Singh V.K., Yardley J.H., and Wu T.T. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 26 (2002) 1276-1285
53. Park DY, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V, Zukerberg LR, et al. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Pathol; 2008 Jan 25 [Epub ahead of print].
54. Morson B.C., Jass J.R., and Sobin L.H. Precancerous lesions of the gastrointestinal tract: a histological classification (1985), Bailliere Tindall, London
55. Murayama H., Kikuchi M., Enjoji M., Morita N., and Haraguchi Y. Changes in gastric mucosa that antedate gastric carcinoma. Cancer 66 (1990) 2017-2026
56. Ghandur-Mnaymneh L., Paz J., Roldan E., and Cassady J. Dysplasia of nonmetaplastic gastric mucosa A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol 12 (1988) 96-114
57. Grundmann E. Histologic types and possible initial stages in early gastric carcinoma. Beitr Pathol 154 (1975) 256-280
58. Lynch H.T., Grady W., Suriano G., and Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol 90 (2005) 114-133 discussion 33
59. Carneiro F., Huntsman D.G., Smyrk T.C., Owen D.A., Seruca R., Pharoah P., et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203 (2004) 681-687
60. Charlton A., Blair V., Shaw D., Parry S., Guilford P., and Martin I.G. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 53 (2004) 814-820
61. Rugge M., Leandro G., Farinati F., Di Mario F., Sonego F., Cassaro M., et al. Gastric epithelial dysplasia How clinicopathologic background relates to management. Cancer 76 (1995) 376-382
62. Everett S.M., and Axon A.T. Early gastric cancer in Europe. Gut 41 (1997) 142-150
63. Abraham S.C., Park S.J., Lee J.H., Mugartegui L., and Wu T.T. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol 16 (2003) 786-795
64. Tamura G., Maesawa C., Suzuki Y., Tamada H., Satoh M., Ogasawara S., et al. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res 54 (1994) 1149-1151
65. Lee J.H., Abraham S.C., Kim H.S., Nam J.H., Choi C., Lee M.C., et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161 (2002) 611-618
66. Maesawa C., Tamura G., Suzuki Y., Ogasawara S., Sakata K., Kashiwaba M., et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 176 (1995) 249-258
67. Nakatsuru S., Yanagisawa A., Furukawa Y., Ichii S., Kato Y., Nakamura Y., et al. Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum Mol Genet 2 (1993) 1463-1465
68. Sanz-Ortega J., Sanz-Esponera J., Caldes T., Gomez de la Concha E., Sobel M.E., and Merino M.J. LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions Prognostic implications. Pathol Res Pract 192 (1996) 1206-1210
69. Sakurai S., Sano T., Maeshima A., Kashiwabara K., Oyama T., Fukuda T., et al. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch 427 (1995) 119-124
70. Feng C.W., Wang L.D., Jiao L.H., Liu B., Zheng S., and Xie X.J. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2 (2002) 8
71. Nogueira A.M., Carneiro F., Seruca R., Cirnes L., Veiga I., Machado J.C., et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer 86 (1999) 1649-1656
72. Lan J., Xiong Y.Y., Lin Y.X., Wang B.C., Gong L.L., Xu H.S., et al. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol 9 (2003) 54-58
73. Shiao Y.H., Rugge M., Correa P., Lehmann H.P., and Scheer W.D. p53 alteration in gastric precancerous lesions. Am J Pathol 144 (1994) 511-517
74. Brito M.J., Williams G.T., Thompson H., and Filipe M.I. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut 35 (1994) 1697-1700
75. Lauwers G.Y., Wahl S.J., Melamed J., and Rojas-Corona R.R. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 88 (1993) 1916-1919
76. Chang M.S., Kim H.S., Kim C.W., Kim Y.I., Lan Lee B., and Kim W.H. Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. Hum Pathol 33 (2002) 415-420
77. Rugge M., Shiao Y.H., Correa P., Baffa R., and DiMario F. Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 1 (1992) 551-554
78. Joypaul B.V., Newman E.L., Hopwood D., Grant A., Qureshi S., Lane D.P., et al. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study. J Pathol 170 (1993) 279-283
79. Teh M., Tan K.B., Seet B.L., and Yeoh K.G. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Cancer 95 (2002) 499-505
80. Morgan C., Jenkins G.J., Ashton T., Griffiths A.P., Baxter J.N., Parry E.M., et al. Detection of p53 mutations in precancerous gastric tissue. Br J Cancer 89 (2003) 1314-1319
81. Stemmermann G., Heffelfinger S.C., Noffsinger A., Hui Y.Z., Miller M.A., and Fenoglio-Preiser C.M. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25 (1994) 968-981
82. Isogaki J., Shinmura K., Yin W., Arai T., Koda K., Kimura T., et al. Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. Cancer Detect Prev 23 (1999) 204-214
83. Kim J.J., Baek M.J., Kim L., Kim N.G., Lee Y.C., Song S.Y., et al. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Lab Invest 79 (1999) 1113-1120
84. Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Terashima M., et al. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180 (1996) 371-377
85. Leung W.K., Kim J.J., Kim J.G., Graham D.Y., and Sepulveda A.R. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 156 (2000) 537-543
86. Kashiwagi K., Watanabe M., Ezaki T., Kanai T., Ishii H., Mukai M., et al. Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 82 (2000) 1814-1818
87. Rugge M., Bersani G., Bertorelle R., Pennelli G., Russo V.M., Farinati F., et al. Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena Italy. J Clin Pathol 58 (2005) 805-810
88. Koshiba M., Ogawa O., Habuchi T., Hamazaki S., Shimada T., Takahashi R., et al. Infrequent ras mutation in human stomach cancers. Jpn J Cancer Res 84 (1993) 163-167
89. Kihana T., Tsuda H., Hirota T., Shimosato Y., Sakamoto H., Terada M., et al. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 82 (1991) 308-314
90. Kobayashi K., Okamoto T., Takayama S., Akiyama M., Ohno T., and Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. Eur J Cancer 36 (2000) 1113-1119
91. Kim H.S., Woo D.K., Bae S.I., Kim Y.I., and Kim W.H. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 80 (2000) 57-64
92. To K.F., Leung W.K., Lee T.L., Yu J., Tong J.H., Chan M.W., et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102 (2002) 623-628
93. Kang G.H., Shim Y.H., Jung H.Y., Kim W.H., Ro J.Y., and Rhyu M.G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61 (2001) 2847-2851
94. Kang G.H., Lee S., Kim J.S., and Jung H.Y. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 83 (2003) 635-641
95. Kirikoshi H., and Katoh M. Expression of TFF1 TFF2 and TFF3 in gastric cancer. Int J Oncol 21 (2002) 655-659
96. Taupin D., Pedersen J., Familari M., Cook G., Yeomans N., and Giraud A.S. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 81 (2001) 397-408
97. Cassaro M., Rugge M., Tieppo C., Giacomelli L., Velo D., Nitti D., et al. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol 60 (2007) 615-621
98. Burke A.P., Sobin L.H., Shekitka K.M., and Helwig E.B. Dysplasia of the stomach and Barrett esophagus: a follow-up study. Mod Pathol 4 (1991) 336-341
99. Lansdown M., Quirke P., Dixon M.F., Axon A.T., and Johnston D. High-grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut 31 (1990) 977-983
100. Yamada H., Ikegami M., Shimoda T., Takagi N., and Maruyama M. Long-term follow-up study of gastric adenoma/dysplasia. Endoscopy 36 (2004) 390-396
101. Rugge M., Cassaro M., Di Mario F., Leo G., Leandro G., Russo V.M., et al. The long term outcome of gastric non-invasive neoplasia. Gut 52 (2003) 1111-1116
102. Weinstein W.M., and Goldstein N.S. Gastric dysplasia and its management. Gastroenterology 107 (1994) 1543-1545
103. Rugge M., Nitti D., Farinati F., di Mario F., and Genta R.M. Non-invasive neoplasia of the stomach. Eur J Gastroenterol Hepatol 17 (2005) 1191-1196
104. Di Gregorio C., Morandi P., Fante R., and De Gaetani C. Gastric dysplasia A follow-up study. Am J Gastroenterol 88 (1993) 1714-1719
105. Saraga E.P., Gardiol D., and Costa J. Gastric dysplasia. A histological follow-up study. Am J Surg Pathol 11 (1987) 788-796
106. Fertitta A.M., Comin U., Terruzzi V., Minoli G., Zambelli A., Cannatelli G., et al., Gastrointestinal Endoscopic Pathology Study Group. Clinical significance of gastric dysplasia: a multicenter follow-up study. Endoscopy 25 (1993) 265-268
107. Kokkola A., Haapiainen R., Laxen F., Puolakkainen P., Kivilaakso E., Virtamo J., et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol 49 (1996) 979-984
108. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 5 (2002) 1-5